SODIUM BICARBONATE injection, solution

Land: USA

Sprog: engelsk

Kilde: NLM (National Library of Medicine)

Køb det nu

Hent Produktets egenskaber (SPC)
19-11-2021

Aktiv bestanddel:

SODIUM BICARBONATE (UNII: 8MDF5V39QO) (BICARBONATE ION - UNII:HN1ZRA3Q20, SODIUM CATION - UNII:LYR4M0NH37)

Tilgængelig fra:

Hospira, Inc.

Indgivelsesvej:

INTRAVENOUS

Recept type:

PRESCRIPTION DRUG

Terapeutiske indikationer:

Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments. Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis ― e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. But since an appreciable time interval may elapse before

Produkt oversigt:

Sodium Bicarbonate Injection, USP is supplied in the following dosage forms: List No. Dosage Form Conc. % mg/mL (NaHCO3 ) mEq/mL (Na+ ) mEq/mL (HCO3 ― ) mEq/Container size (mL)  mOsmol  pH 6637 6625 4900 4916 1594 5534 Abboject® Syringe Fliptop Vial Abboject® Syringe (Pediatric) Abboject® Syringe LVP Glass Container Abboject® Syringe (Infant) 8.4 8.4 8.4 7.5 5.0 4.2 84 84 84 75 50 42 1.0 1.0 1.0 0.9 0.6 0.5 1.0 1.0 1.0 0.9 0.6 0.5 50/50 50/50 10/10 44.6/50 297.5/500 5/10 2/mL 2/mL 2/mL 1.79/mL 1190/liter 1/mL 8.0 (7.0 to 8.5) 7.8 (7.0 to 8.5) 8.0 (7.0 to 8.5) 8.0 (7.0 to 8.5) 7.8 (7.0 to 8.5) 8.0 (7.0 to 8.5) Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Revised: October, 2005     ©Hospira 2005                                                    EN-1064                                               Printed in USA HOSPIRA, INC., LAKE FOREST, IL 60045 USA ABBOJECT® is a trademark of the Abbott group of companies.

Autorisation status:

unapproved drug other

Produktets egenskaber

                                SODIUM BICARBONATE- SODIUM BICARBONATE INJECTION, SOLUTION
HOSPIRA, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
SODIUM BICARBONATE
INJECTION, USP
FOR CORRECTION OF METABOLIC ACIDOSIS AND
OTHER CONDITIONS REQUIRING SYSTEMIC ALKALINIZATION.
ABBOJECT SYRINGE
LVP GLASS CONTAINER
FLIPTOP VIAL
R only
DESCRIPTION
Sodium Bicarbonate Injection, USP is a sterile, nonpyrogenic,
hypertonic solution of
sodium bicarbonate (NaHCO ) in water for injection for administration
by the
intravenous route as an electrolyte replenisher and systemic
alkalizer.
Solutions are offered in concentrations of 4.2%, 5.0%, 7.5% and 8.4%.
See table in
HOW SUPPLIED section for contents and characteristics.
Solution in LVP container has 0.9 mg/mL of edetate disodium, anhydrous
added as a
stabilizer.
The solutions contain no bacteriostat, antimicrobial agent or added
buffer and are
intended only for use as a single-dose injection. When smaller doses
are required, the
unused portion should be discarded with the entire unit.
Sodium bicarbonate, 84 mg is equal to one milliequivalent each of Na
and HCO ¯.
Sodium Bicarbonate, USP is chemically designated NaHCO , a white
crystalline powder
soluble in water.
Water for Injection, USP is chemically designated H O.
CLINICAL PHARMACOLOGY
Intravenous sodium bicarbonate therapy increases plasma bicarbonate,
buffers excess
hydrogen ion concentration, raises blood pH and reverses the clinical
manifestations of
acidosis.
Sodium bicarbonate in water dissociates to provide sodium (Na ) and
bicarbonate
(HCO ¯) ions. Sodium (Na ) is the principal cation of the
extracellular fluid and plays a
large part in the therapy of fluid and electrolyte disturbances.
Bicarbonate (HCO ¯) is a
®
x
3
+
3
3
2
+
3
+
large part in the therapy of fluid and electrolyte disturbances.
Bicarbonate (HCO ¯) is a
normal constituent of body fluids and the normal plasma level ranges
fr
                                
                                Læs hele dokumentet
                                
                            

Søg underretninger relateret til dette produkt